Skip to main content
. 2020 Aug 11;10:1579. doi: 10.3389/fonc.2020.01579

FIGURE 1.

FIGURE 1

Immune and stromal scores are associated with AML clinical parameters. (A,B) Distribution of immune scores (A) and stromal scores (B) for AML FAB subtypes. (C,D) The correlation between immune scores (C) and stromal scores (D) and AML cytogenetic risk. (E,F) Kaplan–Meier survival curve based on immunes (E) and stromal scores (F). AML, acute myeloid leukemia.